Le Lézard
Classified in: Business, Covid-19 virus
Subjects: EARNINGS, Conference Call, Webcast

Gartner Reports Second Quarter 2020 Financial Results


Gartner, Inc. (NYSE: IT), the world's leading research and advisory company, today reported results for the second quarter of 2020 and updated its financial outlook for the full year 2020. Additional information regarding the Company's results and updated 2020 financial outlook are provided in an earnings supplement available on the Company's Investor Relations website at https://investor.gartner.com.

Gene Hall, Gartner's Chief Executive Officer, commented, "We had a strong second quarter despite the challenging macroeconomic environment. Leaders across the enterprise are facing more disruptive change than ever before and Gartner is the best source of help for these leaders. As we enter the second half of 2020, we've restored targeted spending to ensure we're well-positioned for long-term growth coming out of the downturn."

CONFERENCE CALL INFORMATION

The Company will host a webcast call at 8:00 a.m. Eastern time on Tuesday, August 4, 2020 to discuss the Company's financial results. The call will be available via the Company's website at https://investor.gartner.com or by dialing 844-413-7151 (conference ID 4279431). A replay of the webcast will be available on the Company's website for approximately 30 days following the call.

CONSOLIDATED RESULTS HIGHLIGHTS
(Unaudited; $ in millions, except per share amounts)

 

Three Months Ended

 

 

 

 

 

 

June 30,

 

 

 

Inc/(Dec)

 

2020

 

2019

 

Inc/(Dec)

 

FX Neutral

GAAP Metrics:

 

 

 

 

 

 

 

 

Revenues

 

$

973

 

 

$

1,071

 

 

(9.1)

%

 

(7.6)

%

Net income

 

55

 

 

103

 

 

(46.7)

%

 

na

Diluted EPS

 

0.61

 

 

1.13

 

 

(46.0)

%

 

na

Operating cash flow

 

343

 

 

227

 

 

51.6

%

 

na

Non-GAAP Metrics:

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

$

192

 

 

$

185

 

 

4.0

%

 

6.0

%

Adjusted EPS

 

1.20

 

 

1.45

 

 

(17.2)

%

 

na

Free cash flow

 

322

 

 

188

 

 

71.1

%

 

na

na=not available.

 

SEGMENT RESULTS HIGHLIGHTS

Our segment results for the three months ended June 30, 2020 were as follows (Unaudited; $ in millions):

 

 

Research

 

Conferences

 

Consulting

GAAP Metrics:

 

 

 

 

 

 

Revenues

 

$

875

 

 

$

?

 

 

$

97

 

Inc/(Dec)

 

6.0

%

 

nm

 

(5.9)

%

Inc/(Dec) - FX neutral

 

7.8

%

 

nm

 

(5.1)

%

Gross contribution

 

$

633

 

 

$

(11)

 

 

$

34

 

Inc/(Dec)

 

10.5

%

 

(113.9)

%

 

(2.0)

%

Contribution margin

 

72.3

%

 

nm

 

34.4

%

nm = not meaningful.

 

Additional details regarding our segment results can be obtained from the earnings supplement, our quarterly report on Form 10?Q filed with the SEC on August 4, 2020 and our webcast.

Certain financial metrics contained in this Press Release are considered non-GAAP financial measures. Definitions of these non-GAAP financial measures are included in this Press Release under "Non-GAAP Financial Measures" and the related reconciliations are under "Supplemental Information ? Non-GAAP Reconciliations." In this Press Release, some totals may not add due to rounding and percentage changes are based on the whole number and recalculation based on millions may yield a different result.

ABOUT GARTNER

Gartner, Inc. (NYSE: IT) is the world's leading research and advisory company and a member of the S&P 500. We equip business leaders with indispensable insights, advice and tools to achieve their mission?critical priorities today and build the successful organizations of tomorrow. Our unmatched combination of expert-led, practitioner-sourced and data-driven research steers clients toward the right decisions on the issues that matter most. We are a trusted advisor and an objective resource for more than 14,000 enterprises in more than 100 countries ? across all major functions, in every industry and enterprise size. To learn more about how we help decision makers fuel the future of business, visit gartner.com.

FORWARD LOOKING STATEMENTS

Statements contained in this press release regarding the Company's growth and prospects, projected financial results, long-term objectives, and all other statements in this release other than recitation of historical facts are forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements involve known and unknown risks, estimates, uncertainties and other factors that may cause actual results to be materially different, and are currently, or in the future could be, amplified by the COVID-19 pandemic. Such factors include, but are not limited to, the following: uncertainty of the magnitude, duration, geographic reach and impact on the global economy of the COVID-19 pandemic; the current, and uncertain future, impact of the COVID-19 pandemic and governments' responses to it on our business, growth, reputation, projections, prospects, financial condition, operations, cash flows, and liquidity; the adequacy or effectiveness or steps we take to respond to the crisis, including cost reduction or other mitigation programs; our ability to recover potential claims under our event cancellation insurance; our ability to achieve and effectively manage growth, including our ability to integrate our acquisitions and consummate and integrate future acquisitions; our ability to pay our debt obligations; our ability to maintain and expand our products and services; our ability to expand or retain our customer base; our ability to grow or sustain revenue from individual customers; our ability to attract and retain a professional staff of research analysts and consultants as well as experienced sales personnel upon whom we are dependent; our ability to achieve continued customer renewals and achieve new contract value, backlog and deferred revenue growth in light of competitive pressures; our ability to carry out our strategic initiatives and manage associated costs; our ability to successfully compete with existing competitors and potential new competitors; our ability to enforce or protect our intellectual property rights; additional risks associated with international operations, including foreign currency fluctuations; the U.K.'s exit from the European Union and its impact on our results; the impact of restructuring and other charges on our businesses and operations; cybersecurity incidents; general economic conditions; changes in macroeconomic and market conditions and market volatility (including developments and volatility arising from the COVID-19 pandemic), including interest rates and the effect on the credit markets and access to capital; risks associated with the creditworthiness, budget cuts, and shutdown of governments and agencies; the impact of changes in tax policy and heightened scrutiny from various taxing authorities globally; uncertainty from the expected discontinuance of LIBOR and transition to any other interest rate benchmark; changes to laws and regulations; and other factors described under "Risk Factors" in our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, which can be found on Gartner's website at https://investor.gartner.com and the SEC's website at www.sec.gov. Forward-looking statements included herein speak only as of the date hereof and Gartner disclaims any obligation to revise or update such statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events or circumstances, except as required by applicable law.

NON-GAAP FINANCIAL MEASURES

Certain financial measures used in this Press Release are not defined by U.S. generally accepted accounting principles ("GAAP") and as such are considered non-GAAP financial measures. We provide these measures to enhance the user's overall understanding of the Company's current financial performance and the Company's prospects for the future. Investors are cautioned that these non-GAAP financial measures may not be defined in the same manner by other companies and, as a result, may not be comparable to other similarly titled measures used by other companies. Also, these non-GAAP financial measures should not be construed as alternatives, or superior, to other measures determined in accordance with GAAP. The non-GAAP financial measures used in this Press Release are defined below.

Adjusted EBITDA and Adjusted EBITDA Margin: Represents GAAP net income (loss) adjusted for: (i) interest expense, net; (ii) tax provision (benefit), as applicable; (iii) other expense/income, net; (iv) stock-based compensation expense; (v) depreciation, amortization, and accretion; (vi) the amortization of non-cash fair value adjustments on pre-acquisition deferred revenues, as applicable; (vii) acquisition and integration charges and certain other non-recurring items; and (viii) gain/loss on divestitures, as applicable. Adjusted EBITDA Margin represents Adjusted EBITDA divided by GAAP Revenue. We believe Adjusted EBITDA and Adjusted EBITDA Margin are important measures of our recurring operations as they exclude items not representative of our core operating results.

Adjusted Net Income: Represents GAAP net income (loss) adjusted for the impact of certain items directly related to acquisitions and other non-recurring items. These adjustments include: (i) the amortization of acquired intangibles; (ii) acquisition and integration charges and other non-recurring items; (iii) the amortization of non-cash fair value adjustments on pre-acquisition deferred revenues, as applicable; (iv) gain/loss on divestitures and other similar items, as applicable; (v) the non-cash gain/loss on de-designated interest rate swaps, as applicable; and (vi) the related tax effect, as applicable. We believe Adjusted Net Income is an important measure of our recurring operations as it excludes items that may not be indicative of our core operating results.

Adjusted EPS: Represents GAAP diluted EPS adjusted for the impact of certain items directly related to acquisitions and other non-recurring items. These adjustments include on a per share basis: (i) the amortization of acquired intangibles; (ii) acquisition and integration charges and other non-recurring items; (iii) the amortization of non-cash fair value adjustments on pre-acquisition deferred revenues, as applicable; (iv) the gain/loss on divestitures and other similar items, as applicable; (v) the non-cash gain/loss on de-designated interest rate swaps, as applicable; and (vi) the related tax effect, as applicable. We believe Adjusted EPS is an important measure of our recurring operations as it excludes items that may not be indicative of our core operating results.

Free Cash Flow: Represents cash provided by operating activities determined in accordance with GAAP less payments for capital expenditures. The definition of Free Cash Flow no longer excludes acquisition and other non-recurring items as we believe this change better captures actual cash generated in the period for capital allocation. We believe Free Cash Flow is an important measure of the recurring cash generated by the Company's core operations that may be available to be used to repay debt obligations, repurchase our stock, invest in future growth through new business development activities, or make acquisitions.

Foreign Currency Neutral (FX Neutral): We provide foreign currency neutral dollar amounts and percentages for our contract values, revenues, certain expenses, and other metrics. These foreign currency neutral dollar amounts and percentages eliminate the effects of exchange rate fluctuations and thus provide a more accurate and meaningful trend in the underlying data being measured. We calculate foreign currency neutral dollar amounts by converting the underlying amounts in local currency for different periods into U.S. dollars by applying the same foreign exchange rates to all periods presented.

Non-GAAP Interest: Interest expense, net excluding amortization of certain deferred financing fees.

SUPPLEMENTAL INFORMATION - NON-GAAP RECONCILIATIONS

The tables below provide reconciliations of certain Non-GAAP financial measures used in this Press Release with the most directly comparable GAAP measure. See "Non-GAAP Financial Measures" above for definitions of these measures.

Reconciliation - GAAP Net Income to Adjusted EBITDA (Unaudited; in millions)

 

 

Three Months Ended June 30,

 

 

2020

 

2019

GAAP net income

 

$

55

 

 

$

103

 

Interest expense, net

 

30

 

 

25

 

Other expense, net (a)

 

10

 

 

?

 

Tax provision

 

4

 

 

(12

)

Operating income

 

99

 

 

116

 

Adjustments:

 

 

 

 

Stock-based compensation expense (b)

 

16

 

 

13

 

Depreciation, amortization and accretion (c)

 

54

 

 

52

 

Acquisition and integration charges and other non-recurring items (d)

 

23

 

 

3

 

Rounding

 

 

 

1

 

Adjusted EBITDA

 

$

192

 

 

$

185

 

(a)

Consists of the non-cash loss on de-designated interest rate swaps as a result of the prepayment of $787.9 million under the Term A loan facility and all amounts outstanding under the Revolving credit facility on June 30, 2020.

(b)

Consists of charges for stock-based compensation awards.

(c)

Includes depreciation expense, amortization of intangibles and accretion expense.

(d)

Consists of incremental and directly-related charges related to acquisitions, workforce reductions and other non-recurring items.

Reconciliation - GAAP Net Income to Adjusted Net Income and Adjusted EPS
(Unaudited; in millions, except per share amounts)

 

 

Three Months Ended June 30,

 

 

2020

 

2019

 

 

Amount

 

Per Share

 

Amount

 

Per Share

GAAP net income

 

$

55

 

 

$

0.61

 

 

$

103

 

 

$

1.13

 

Acquisition and other adjustments:

 

 

 

 

 

 

 

 

Amortization of acquired intangibles (a)

 

31

 

 

0.35

 

 

32

 

 

0.35

 

Acquisition and integration charges and other non-recurring items (b), (c)

 

26

 

 

0.29

 

 

5

 

 

0.05

 

Loss on de-designated interest rate swaps (d)

 

10

 

 

0.11

 

 

?

 

 

?

 

Tax impact of adjustments (e)

 

(16

)

 

(0.17

)

 

(9

)

 

(0.09

)

Rounding

 

?

 

 

?

 

 

1

 

 

0.01

 

Adjusted net income and Adjusted EPS (f)

 

$

107

 

 

$

1.20

 

 

$

132

 

 

$

1.45

 

(a)

Consists of non-cash amortization charges from acquired intangibles.

(b)

Consists of incremental and directly-related charges related to acquisitions, workforce reductions and other non-recurring items.

(c)

Includes the amortization and write-off of deferred financing fees, which are recorded in Interest expense, net in the Company's accompanying Condensed Consolidated Statements of Operations and in the Adjusted EBITDA table above.

(d)

Consists of the non-cash loss on de-designated interest rate swaps as a result of the prepayment of $787.9 million under the Term A loan facility and all amounts outstanding under the Revolving credit facility on June 30, 2020.

(e)

The blended effective tax rates on the adjustments were approximately 22.8% and 23.1% for the three months ended June 30, 2020 and 2019, respectively.

(f)

Adjusted EPS was calculated based on 89.8 million and 91.2 million diluted shares for the six months ended June 30, 2020 and 2019, respectively.

Reconciliation - GAAP Cash Provided by Operating Activities to Free Cash Flow (Unaudited; in millions)

 

 

Three Months Ended June 30,

 

 

2020

 

2019

GAAP cash provided by operating activities

 

$

343

 

 

$

227

 

Cash paid for capital expenditures

 

(21

)

 

(39

)

Free Cash Flow (a)

 

$

322

 

 

$

188

 

(a)

Previously reported Free Cash Flow added back cash paid for acquisition, integration, and other non-recurring items. These items totaled $9 million for the three months ended June 30, 2019 and previously reported Free Cash Flow was $197 million.

GARTNER, INC.

Condensed Consolidated Statements of Operations

(Unaudited; in millions, except per share data)

 

Three Months Ended June 30,

 

2020

 

2019

Revenues:

 

 

 

Research

$

875.3

 

 

$

826.1

 

Conferences

$

0.3

 

 

$

141.2

 

Consulting

$

97.5

 

 

$

103.6

 

Total revenues

$

973.1

 

 

$

1,070.9

 

Costs and expenses:

 

 

 

Cost of services and product development

$

322.5

 

 

$

388.0

 

Selling, general and administrative

$

494.8

 

 

$

515.0

 

Depreciation

$

22.7

 

 

$

20.1

 

Amortization of intangibles

$

31.2

 

 

$

32.2

 

Acquisition and integration charges (credits)

$

2.2

 

 

$

(0.4

)

Total costs and expenses

$

873.4

 

 

$

954.9

 

Operating income

$

99.7

 

 

$

116.0

 

Interest expense, net

$

(30.3

)

 

$

(24.8

)

Other expense, net

$

(10.4

)

 

$

(0.2

)

Income before income taxes

$

59.0

 

 

$

91.0

 

Provision/(Benefit) for income taxes

$

3.9

 

 

$

(12.4

)

Net income

$

55.1

 

 

$

103.4

 

 

 

 

 

Net income per share:

 

 

 

Basic

$

0.62

 

 

$

1.15

 

Diluted

$

0.61

 

 

$

1.13

 

Weighted average shares outstanding:

 

 

 

Basic

89.3

 

 

90.1

 

Diluted

89.8

 

 

91.2

 

Source: Gartner, Inc.

Gartner-IR


These press releases may also interest you

at 12:50
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired QuidelOrtho Corporation ("QuidelOrtho"...

at 11:40
The "Global Needle Coke Market: Focus on Application, Type, Grade, End Use, and Country-Level Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global needle coke market was valued at $3.05...

at 11:15
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....

at 11:15
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...

at 09:35
Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research...

at 09:25
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...



News published on and distributed by: